PharmaCyte Biotech, Inc. Annual Net Cash Provided by (Used in) Financing Activities in USD from 2010 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
PharmaCyte Biotech, Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2010 to 2023.
  • PharmaCyte Biotech, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending July 31, 2024 was -$10.2M, a 262% decline year-over-year.
  • PharmaCyte Biotech, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was -$10.7M, a 21% increase from 2022.
  • PharmaCyte Biotech, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was -$13.6M, a 116% decline from 2021.
  • PharmaCyte Biotech, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2021 was $87.3M, a 1783% increase from 2020.
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$10.7M +$2.85M +21% May 1, 2023 Apr 30, 2024 10-K 2024-08-13
2022 -$13.6M -$101M -116% May 1, 2022 Apr 30, 2023 10-K 2024-08-13
2021 $87.3M +$82.7M +1783% May 1, 2021 Apr 30, 2022 10-K 2023-07-31
2020 $4.64M +$1.91M +70.1% May 1, 2020 Apr 30, 2021 10-K 2022-07-28
2019 $2.73M +$383K +16.4% May 1, 2019 Apr 30, 2020 10-K 2021-08-10
2018 $2.34M -$339K -12.6% May 1, 2018 Apr 30, 2019 10-K 2020-08-13
2017 $2.68M -$2.2M -45.1% May 1, 2017 Apr 30, 2018 10-K 2019-08-13
2016 $4.88M May 1, 2016 Apr 30, 2017 10-K 2018-07-20
2012 $1.22M +$131K +12% May 1, 2012 Apr 30, 2013 10-K 2013-07-29
2011 $1.09M +$808K +287% May 1, 2011 Apr 30, 2012 10-K 2013-07-29
2010 $282K May 1, 2010 Apr 30, 2011 10-K 2012-08-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.